Published in Lab Law Weekly, April 22nd, 2005
In addition, the license covers "one-shot" emergency vaccination strategies that have proven to be effective in relevant animal models.
"This license uniquely positions Crucell to commercialize an Ebola vaccine," said Crucell CEO Dr. Ronald Brus. "It...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.